Literature DB >> 32439817

Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2.

Hoi See Tsao1,2,3, Hannah M Chason2, Deirdre M Fearon2,3.   

Abstract

Immune thrombocytopenia (ITP) is a potential presentation of COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral testing should be considered in these patients to allow for appropriate hospital triaging and isolation to limit community spread and health care worker infection during epidemics or pandemics. ITP is characterized by isolated thrombocytopenia. Approximately two-thirds of children with primary ITP have a history of a viral infection during the previous month.1,2 Viruses commonly identified as triggers include cytomegalovirus, hepatitis C, herpes, varicella zoster, Epstein-Barr, influenza, and HIV.3-7 In this case report, we describe the first documented case of a pediatric patient with ITP who tested positive for SARS-CoV-2. This case raises awareness of ITP as a possible pediatric presentation of coronavirus disease.
Copyright © 2020 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2020        PMID: 32439817     DOI: 10.1542/peds.2020-1419

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

Review 1.  Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations.

Authors:  Vikram Thakur; Radha Kanta Ratho; Pradeep Kumar; Shashi Kant Bhatia; Ishani Bora; Gursimran Kaur Mohi; Shailendra K Saxena; Manju Devi; Dhananjay Yadav; Sanjeet Mehariya
Journal:  J Clin Med       Date:  2021-01-24       Impact factor: 4.241

2.  The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.

Authors:  Lucia Novelli; Francesca Motta; Maria De Santis; Aftab A Ansari; M Eric Gershwin; Carlo Selmi
Journal:  J Autoimmun       Date:  2020-12-14       Impact factor: 7.094

3.  Immune thrombocytopenia in a child with COVID-19: Is it the calm after the (cytokine) storm?

Authors:  Giulia Ceglie; Maria Antonietta De Ioris; Stefania Mercadante; Nicole Olivini; Francesca Del Bufalo; Silvio Marchesani; Francesca Cocca; Emanuela Monteferrario; Emilia Boccieri; Jolanda Pianese; Giuseppe Palumbo
Journal:  Pediatr Blood Cancer       Date:  2021-09-07       Impact factor: 3.167

Review 4.  COVID-19 Legacy.

Authors:  Amit P Ladani; Muruga Loganathan; Murali K Kolikonda; Steven Lippmann
Journal:  South Med J       Date:  2021-12       Impact factor: 0.954

Review 5.  SARS-CoV-2 triggering autoimmune diseases.

Authors:  Leila Mobasheri; Mohammad Hossein Nasirpour; Elham Masoumi; Afsaneh Foolady Azarnaminy; Mozhdeh Jafari; Seyed-Alireza Esmaeili
Journal:  Cytokine       Date:  2022-04-05       Impact factor: 3.926

6.  Immune thrombocytopenia secondary to COVID-19 infection:  Report of two cases.

Authors:  Evangelia Behlivani; Athanasios Tragiannidis; Emmanuel Hatzipantelis; Paraskevi Panagopoulou
Journal:  Pediatr Blood Cancer       Date:  2021-06-01       Impact factor: 3.838

7.  SARS-CoV-2, the autoimmune virus.

Authors:  Gilad Halpert; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2020-10-28       Impact factor: 9.754

Review 8.  Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review.

Authors:  Sukrita Bhattacharjee; Mainak Banerjee
Journal:  SN Compr Clin Med       Date:  2020-09-19

9.  Epidemiology and Viral Etiology of Pediatric Immune Thrombocytopenia through Korean Public Health Data Analysis.

Authors:  Jae Hee Lim; Yu Kyeong Kim; So Hyeon Min; Sang Won Kim; Young Hwan Lee; Jae Min Lee
Journal:  J Clin Med       Date:  2021-03-25       Impact factor: 4.241

10.  Persistent immune thrombocytopaenic purpura associated with SARS-CoV-2 infection.

Authors:  Yoshiki Furukawa; Miki Ando; Yoko Azusawa; Shintaro Kinoshita; Sakiko Harada; Tomonori Ochiai; Tadahiro Honda; Kazuya Sugimoto; Yoko Tabe; Norio Komatsu; Jun Ando
Journal:  EJHaem       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.